InsidersTradesSigma
Follow the Great Basin Scientific, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 9 February 2016 (Levée d'options). Among the most active insiders: Spafford David. All data is accessible without an account.
Analysts rate Great Basin Scientific, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Great Basin Scientific, Inc. is a company focused on developing molecular diagnostic tests. It specializes in the rapid and accurate detection of infections and diseases.